WAVE LIFE SCIENCES LTD. Increase (Decrease) in Prepaid Expense and Other Assets
WAVE LIFE SCIENCES LTD. (WVE) reported Increase (Decrease) in Prepaid Expense and Other Assets of $4.42 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2019-11-05
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-09-30 was $4.56M, a 219.38% increase year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-06-30 was -$779.00K, a 120.65% decline year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-03-31 was $637.00K, a 31.34% increase year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for the quarter ending 2018-12-31 was $4.78M, a 196.10% increase year-over-year.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $10.47M, a 90.28% increase from fiscal 2017.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $5.50M, a 311.52% increase from fiscal 2016.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for fiscal 2016 was $1.34M.
- WAVE LIFE SCIENCES LTD. increase (decrease) in prepaid expense and other assets for fiscal 2015 was -$130.00K, a 1183.33% decline from fiscal 2014.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $3.79M derived: sum of 2 quarters · filed 2019-11-05 | $4.42M 10-Q · filed 2019-11-05 | $9.20M derived: sum of 4 quarters · filed 2019-11-05 | ||
| 2019-06-30 | -$779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$142.00K 10-Q · filed 2019-08-06 | $4.64M derived: sum of 3 quarters · filed 2019-08-06 | $6.07M derived: sum of 4 quarters · filed 2019-11-05 | ||
| 2019-03-31 | $637.00K 10-Q · filed 2019-05-10 | $5.42M derived: sum of 2 quarters · filed 2019-05-10 | $6.85M derived: sum of 3 quarters · filed 2019-11-05 | $10.62M derived: sum of 4 quarters · filed 2019-11-05 | ||
| 2018-12-31 | $4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.21M derived: sum of 2 quarters · filed 2019-11-05 | $9.98M derived: sum of 3 quarters · filed 2019-11-05 | $10.47M 10-K · filed 2019-03-01 | ||
| 2018-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.20M derived: sum of 2 quarters · filed 2019-11-05 | $5.69M 10-Q · filed 2019-11-05 | $7.30M derived: sum of 4 quarters · filed 2019-11-05 | ||
| 2018-06-30 | $3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $4.26M 10-Q · filed 2019-08-06 | $5.87M derived: sum of 3 quarters · filed 2019-08-06 | $7.42M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | $485.00K 10-Q · filed 2019-05-10 | -$515.00K 10-Q · filed 2018-05-09 | $2.10M derived: sum of 2 quarters · filed 2019-05-10 | $3.64M derived: sum of 3 quarters · filed 2019-05-10 | $4.17M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.16M derived: sum of 2 quarters · filed 2019-03-01 | $3.69M derived: sum of 3 quarters · filed 2019-03-01 | $5.50M 10-K · filed 2019-03-01 | $6.50M 10-K · filed 2018-03-12 | |
| 2017-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.07M derived: sum of 2 quarters · filed 2018-11-09 | $3.89M 10-Q · filed 2018-11-09 | $4.76M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $530.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.34M 10-Q · filed 2018-08-09 | $3.21M derived: sum of 3 quarters · filed 2019-03-01 | $1.61M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $1.81M 10-Q · filed 2018-05-09 | $2.68M derived: sum of 2 quarters · filed 2019-03-01 | $1.08M derived: sum of 3 quarters · filed 2019-03-01 | $2.74M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$732.00K derived: sum of 2 quarters · filed 2019-03-01 | $923.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.34M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $52.00K derived: sum of 2 quarters · filed 2017-11-09 | $466.00K 10-Q · filed 2017-11-09 | $296.00K derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.07M 10-Q · filed 2017-08-09 | $1.90M derived: sum of 3 quarters · filed 2018-03-12 | $1.92M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-03-31 | $414.00K 10-Q · filed 2017-05-10 | $244.00K derived: sum of 2 quarters · filed 2018-03-12 | $266.00K derived: sum of 3 quarters · filed 2018-03-12 | $234.00K derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2015-12-31 | -$170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$148.00K derived: sum of 2 quarters · filed 2018-03-12 | -$180.00K derived: sum of 3 quarters · filed 2018-03-12 | -$130.00K 10-K · filed 2018-03-12 | $63.00K 10-K · filed 2016-03-30 | |
| 2015-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$10.00K derived: sum of 2 quarters · filed 2016-11-09 | $40.00K 10-Q · filed 2016-11-09 | $57.00K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $18.00K 10-Q · filed 2016-08-15 | $35.00K derived: sum of 3 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $50.00K 10-Q · filed 2016-05-16 | $67.00K derived: sum of 2 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $12.00K 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | -$5.00K 10-Q · filed 2015-12-17 | |||||
| 2013-12-31 | -$3.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |